Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Peter G, Shields"'
Autor:
Carolyn J Presley, Peter G. Shields, Barbara L. Andersen, Rachel M. Smith, David P. Carbone, Guy N. Brock, Joseph P. McElroy
Publikováno v:
Psychosom Med
OBJECTIVE Lung cancer remains the number one cause of cancer-related mortality worldwide, but less known is that lung cancer patients are among the most psychologically disabled of all cancer groups. Patients with stage-IV non-small cell lung cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0047ca1d30a8ba30cd8f3eca10cb0bee
https://europepmc.org/articles/PMC8831460/
https://europepmc.org/articles/PMC8831460/
Autor:
Peter G. Shields, David P. Carbone, Songzhu Zhao, Madison Grogan, Kai He, Daniel Spakowicz, Abdul Miah, Sandip H. Patel, Lai Wei, Mingjia Li, Erin M. Bertino, Dwight H. Owen, Gregory A. Otterson, Carolyn J Presley, Andrew Johns, Marium Husain
Publikováno v:
Cancer Immunol Immunother
BACKGROUND: Checkpoint inhibitor pneumonitis (CIP) is an immune related adverse event that may complicate treatment with immune checkpoint inhibitors (ICI) and can cause significant morbidity. We sought to identify predictors for the development of C
Autor:
Claire F. Verschraegen, Daniel Spakowicz, Mingjia Li, Kai He, Jarred Burkart, Kari Kendra, Erin M. Bertino, Gregory A. Otterson, Dwight H. Owen, Sandip H. Patel, Carolyn J Presley, Marium Husain, David P. Carbone, Peter G. Shields
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Background The neutrophil to lymphocyte ratio (NLR) is known to be prognostic for patients with advanced cancers treated with immune checkpoint inhibitors (ICI), but has generally been evaluated as a single threshold value at baseline. We evaluated N
Autor:
Gregory A. Otterson, Peter G. Shields, Thomas Edd, Miguel A. Villalona-Calero, Dwight H. Owen, Lai Wei, Erin M. Bertino, Kai He, David P. Carbone
Publikováno v:
Clinical lung cancer
Immunotherapy is a mainstay of treatment for nonesmall-cell lung cancer. Serious immune-related adverse events (irAEs) occur; however, their effect on survival is unclear, and no defined risks factors have been elucidated. In the present study, we fo
Autor:
John C. Grecula, Meng Xu-Welliver, Peter G. Shields, Erin M. Bertino, James L. Fisher, Kai He, Terence M. Williams, K.E. Haglund, Eric D. Miller, David P. Carbone, Jose G. Bazan, Gregory A. Otterson
Publikováno v:
Journal of Thoracic Oncology. 13:426-435
Introduction Elderly patients account for the majority of lung cancer diagnoses but are poorly represented in clinical trials. We evaluated the overall survival (OS) of elderly patients with stage III NSCLC treated with definitive radiation compared
Autor:
J.Kousou Essan, Kai He, Jose G. Bazan, Erin M. Bertino, Terence M. Williams, Carolyn J Presley, Greg Otterson, Eric D. Miller, Peter G. Shields, K.E. Haglund, David P. Carbone, J. Pan, M.X. Welliver, J.M. Brownstein, Xiangyu Yang, S. McElroy, Dwight H. Owen, Michael V. Knopp
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:S90
Purpose/Objective(s) Primary tumor failure is common in patients treated with chemoradiation (CRT) for unresectable LA-NSCLC. Stereotactic body radiation therapy (SBRT) yields high rates of primary tumor control in Stage I NSCLC. This trial tested an
Autor:
Sandip H. Patel, A.L.H. Arnett, Songzhu Zhao, Lai Wei, Kai He, Terence M. Williams, M.X. Welliver, Peter G. Shields, Dwight H. Owen, Erin M. Bertino, D. Hardesty, Greg Otterson, Carolyn J Presley, James B. Elder, K.E. Haglund, Joshua D. Palmer, David P. Carbone, M. Smith, Gabrielle Lopez, Sasha Beyer
Publikováno v:
Journal of Thoracic Oncology. 16:S507
Autor:
Eric D. Miller, John C. Grecula, Meng Xu-Welliver, David P. Carbone, Peter G. Shields, James L. Fisher, Kai He, Erin M. Bertino, Gregory A. Otterson, Jose G. Bazan, Terence M. Williams, K.E. Haglund
Publikováno v:
Radiation Oncology (London, England)
Radiation Oncology, Vol 13, Iss 1, Pp 1-10 (2018)
Radiation Oncology, Vol 13, Iss 1, Pp 1-10 (2018)
Background To compare patterns of care for elderly patients versus non-elderly patients with non-surgically treated stage III non-small cell lung cancer (NSCLC) using the National Cancer Database (NCDB). We hypothesize that elderly patients are less
Autor:
Mark D. Wewers, Peter G. Shields, Joseph P. McElroy, Jo L. Freudenheim, Theodore M. Brasky, Amanda B. Hummon, Ewy Mathé, Min-Ae Song
Publikováno v:
Am J Respir Crit Care Med
Autor:
Jo L. Freudenheim, Catalin Marian, Rachel M. Cole, Peter G. Shields, Theodore M. Brasky, Martha A. Belury, Lisa D. Yee, Adana A.M. Llanos, Shiva Krishnan, Shuvro Roy
Publikováno v:
International Journal of Cancer. 137:2934-2946
There is increasing evidence that chronic inflammation is associated with increased breast cancer risk. Long-chain omega-3 polyunsaturated fatty acids (LCω-3PUFA) may reduce circulating biomarkers of inflammation; however associations of blood LCω-